Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1998 1
2001 2
2002 3
2003 2
2004 5
2005 7
2006 7
2007 12
2008 8
2009 7
2010 9
2011 12
2012 7
2013 4
2014 6
2015 7
2016 6
2017 6
2018 1
2019 8
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 22108511

113 results
Results by year
Filters applied: . Clear all
Page 1
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy.
Farinati F, Giacomin A, Vanin V, Sergio A, Burra P, Cillo U, Di Nolfo A, Del Poggio P, Benvegnu L, Zoli M, Borzio F, Giannini EG, Caturelli E, Cazzagon N, Rapaccini GL, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Farinati F, et al. Eur J Gastroenterol Hepatol. 2012 Feb;24(2):195-202. doi: 10.1097/MEG.0b013e32834e153c. Eur J Gastroenterol Hepatol. 2012. PMID: 22108511
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.
Cillo U, Vitale A, Brolese A, Zanus G, Neri D, Valmasoni M, Bonsignore P, Grigoletto F, Burra P, Farinati F, D'Amico DF. Cillo U, et al. J Surg Oncol. 2007 Mar 1;95(3):213-20. doi: 10.1002/jso.20641. J Surg Oncol. 2007. PMID: 17066432
HCC in living donor liver transplantation: can we expand the Milan criteria?
Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK. Kwon CH, et al. Dig Dis. 2007;25(4):313-9. doi: 10.1159/000106911. Dig Dis. 2007. PMID: 17960066
Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN. Hanouneh IA, et al. Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043. Transplant Proc. 2011. PMID: 22172852
[Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
Fan J, Zhou J, Xu Y, Qiu SJ, Wu ZQ, Yu Y, Huang XW, Tang ZY, Wang YQ. Fan J, et al. Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1227-31. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16796876 Chinese.
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Margarit C, et al. Liver Transpl. 2005 Oct;11(10):1242-51. doi: 10.1002/lt.20398. Liver Transpl. 2005. PMID: 16184539 Free article.
Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
Kim JM, Kwon CH, Joh JW, Kim SJ, Shin M, Kim EY, Moon JI, Jung GO, Choi GS, Lee SK. Kim JM, et al. Transplant Proc. 2010 Apr;42(3):821-4. doi: 10.1016/j.transproceed.2010.02.027. Transplant Proc. 2010. PMID: 20430181
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G. Zavaglia C, et al. Am J Gastroenterol. 2005 Dec;100(12):2708-16. doi: 10.1111/j.1572-0241.2005.00289.x. Am J Gastroenterol. 2005. PMID: 16393224
[Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX, Yan LN. Zhou LX, et al. Ai Zheng. 2006 Jun;25(6):736-9. Ai Zheng. 2006. PMID: 16764771 Free article. Chinese.
Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y. Soejima Y, et al. Transplantation. 2007 Apr 15;83(7):893-9. doi: 10.1097/01.tp.0000259015.46798.ec. Transplantation. 2007. PMID: 17460559
113 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback